Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
NCT00303407 · Status: TERMINATED · Type: OBSERVATIONAL
Last updated 2006-03-16
Summary
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care
Conditions
- Cancer
- Venous Thromboembolism
Interventions
- DRUG
-
nadroparin
Sponsors & Collaborators
-
University Hospital, Geneva
lead OTHER
Principal Investigators
-
Catherine Weber, MD · Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Completion
- 2002-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
NCT01602445 ·Status: COMPLETED
-
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
NCT00199602 ·Status: COMPLETED ·Phase: PHASE3
-
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
NCT01803022 ·Status: COMPLETED
-
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
NCT03134820 ·Status: COMPLETED
-
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
NCT00311753 ·Status: COMPLETED ·Phase: PHASE3
-
Cancer-related Thromboembolic Disease
NCT02785757 ·Status: UNKNOWN ·Phase: NA
-
Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
NCT06714734 ·Status: RECRUITING
-
Predictive Factors for Major Bleeding Risk in Patients Admitted in a Palliative Care Unit
NCT01056978 ·Status: COMPLETED
-
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
NCT03045406 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
NCT01164046 ·Status: TERMINATED ·Phase: PHASE3
-
Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients
NCT03124017 ·Status: COMPLETED ·Phase: NA
-
DOAC - Dosing Options in AntiCoagulation Prophylaxis
NCT07005024 ·Status: RECRUITING ·Phase: PHASE3
-
Chemoprophylaxis Plus Early Ambulation
NCT03862755 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
NCT00375076 ·Status: COMPLETED ·Phase: PHASE3
-
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
NCT02898051 ·Status: UNKNOWN
-
Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
NCT03100071 ·Status: UNKNOWN
-
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
NCT03407469 ·Status: RECRUITING
-
Allo - Cancer - Thrombosis
NCT03563924 ·Status: UNKNOWN
-
Anticoagulation Length in Cancer Associated Thrombosis
NCT01817257 ·Status: TERMINATED ·Phase: PHASE2
-
Prophylactic Anticoagulation for Catheter-related Thrombosis
NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
NCT02706249 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
NCT00876915 ·Status: TERMINATED ·Phase: PHASE3
-
Risk Factors and Prediction Model of Cancer-associated Venous Thromboembolism
NCT05729464 ·Status: UNKNOWN
-
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
NCT00694382 ·Status: COMPLETED ·Phase: PHASE3
-
Implementing VTE Prevention in Ambulatory Cancer Care
NCT07292376 ·Status: ENROLLING_BY_INVITATION ·Phase: NA